chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have hereditary lymphedema in my legs which became much worse/swelling/inner side of the knee where it was very swollen; I have hereditary lymphedema in my legs which became much worse; Having very sharp nerve pain; Stinging burning pain which is extremely sensitive to touch/Burning pain/ stinging burning pain was also behind her knee; Stinging burning pain which is extremely sensitive to touch/Burning pain; I also had a sore swollen lymph node; I also had a sore swollen lymph node; A broken blood vessel in my right eye; This is a spontaneous report from a contactable consumer via COVAES. This non-pregnant 64-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0171) via an unspecified route of administration in the left arm on 29Apr2021 (at 64-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, peripheral neuropathy, and hereditary lymphedema, all from unknown dates and unknown if ongoing. The patient had no allergies, had not received any other vaccines within 4 weeks prior to the COVID vaccine, and had not been diagnosed with COVID-19 prior to vaccination. Concomitant medications included gabapentin, baclofen, bupropion, and cetirizine, all from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EW0151) in the left arm on 07Apr2021 (at the age of 64-years-old) for COVID-19 immunisation. The patient reported on 03May2021, she had hereditary lymphedema in her legs which became much worse within one week following the 2nd shot; further stating it had never been that bad before. The swelling was so severe that she believed it was pressing on nerves because she was having very sharp nerve pain and stinging burning pain which was extremely sensitive to touch. The stinging burning pain was also behind her knee and on the inner side of the knee where it is very swollen. She also had multiple sclerosis so at first she thought it was just from that because at the same time she had burning pain in her left side too and no lymphedema there. She reported that whenever she got sick with a virus it exacerbated her multiple sclerosis and burning pain was one of the symptoms. She also had a sore swollen lymph node under her left arm and a broken blood vessel in her right eye, which she had never had before, 2 days after the second shot. The patient reported that a doctor's office visit was required for the events, and that no treatment was received for the events. The clinical outcomes of the events were not recovered.
DTaP immunization given IM left deltoid on 7/18/07. In AM on 7/20/07, parents noted swelling and redness in left upper arm. Was seen in clinic at 2:15 PM - redness, warmth, swelling and hardness noted from mid left upper arm extending to left shoulder. No other symptoms present. No fever
Day 1: Site of inj pain, headache. Day 2: Sinus congestion, headache, fever up to 102 degrees F. Day 3: Site swollen to orange size, red & hot temp 101 degrees chest rash.
This report describes the occurrence of mercury poisoning in a male child currently 11 years old, who received hep B vaccine recombinant (Engerix B). This report was received as a result of litigation proceedings and has not been confirmed by a physician or other healthcare professional. The subject's past medical history, concurrent conditions, and concurrent medications were not reported. On 7/20/95, 9/29/95, and 6/8/96, the subject received injections of Engerix B. He also received diphtheria and tetanus toxoid and pertussis vaccine (8/12/91, 10/25/91, 12/13/91 and 7/16/96; and Tri-Immunol, 12/9/92); haemophilus influenza type B conjugate vaccine (8/12/91, 10/25/91, 12/13/91, and 8/10/92); MMR II (8/10/92, 7/20/95); and varicella virus vaccine (6/14/96). The attorney alleged that "As a result of the mercury in the thimerosal-containing vaccinations received during these developmental years, the subject now suffers and in the future will continue to suffer from the toxic neurological effects of mercury poisoning." This report of "mercury poisoning" is considered medically serious (OMIC).
Developed mild thrombocytopenia following vaccination, repeat bone marrow shows progression of CMML
Patient called the health dept 9/17/12 at about 1530 with a complaint of feeling as though her throat was tight. Patient denied shortness of breath, lightheadedness, itching or nausea. Patient & mother presented to health dept. on 9/17/12 at about 4:30 pm. Patient symptoms unchanged & now has developed paroxysmal dry coughing.
Herpes zoster; This spontaneous report was received from a lawyer regarding a case in litigation referring to a currently 61-year-old female patient. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unspecified date in 2016 the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (lot#, expiration date, dosage and route of administration were not provided) for the long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient was treated for Herpes Zoster resulting from her use zoster vaccine live(ZOSTAVAX). At the time of the report, the outcome of Herpes Zoster was unknown. The reporter considered Herpes Zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
After multiple vaccines 8/31 patient started with cough, runny nose 2 hours later. On 9/1 with T 38.5 - very red cheeks, large left arm where DTaP was injection.
Initial unsolicited report received from a consumer on 26-Sep-2017 and additional information received on 26-Sep-2017. This case involves a female patient (onset age not reported) who was vaccinated with a 0.5 ml single dose of ADACEL (batch number, expiry date was not reported) in left deltoid via intramuscular route on 28-Jul-2017. The patient's medical history and concomitant medications were not reported. On an unknown date, in the evening same day after vaccination, the patient experienced tingling of the left hand. On an unknown date after the vaccination, the symptoms progressed to include a generalized weakness of the body, left hand was extremely painful and had limited ROM (range of motion) and her hand and arm swelled up. It was also reported that the symptoms had progressed over time. The patient's laboratory data and corrective treatment were not reported. The patient was not recovered from the events. List of documents held by sender: none.
vaccine used past the 12 hour window of use after vial punctured. Stored in fridge entire time and cleaned between each use with alcohol. second dose given 7/14/21 also given past 12 hour window, same lot number different vial.Pt contacted and no adverse reaction, pt states no problems
Symptoms: hard time breathing, sudden increase of my pulse, and sharp pain to the left side of my chest. Diagnosed with Myocarditis in the hospital and Pericarditis at the doctor's office.
Swelling, heat and pain located in the right arm. Swelling from the top of the arm down to the wrist getting progressively worse from 8/1 to 8/3. Pharmacy notified on 8/3. Parent advised to go to urgent care.
I got Shingles. I had a rash, burning and pain on my left side on my left torso. I then went to the urgent care and the provider prescribed antiviral valacyclovir. I still have a rash.
Low grade fever, 3"-4" sized very red circle at point of injection, swelling, pain.
woke from nap w/inconsolable crying & severe redness & swelling to entire lt leg, foot & genitalia-fever 101-mom instructed to give Ibuprofen/DPH & cool compress p/1hr;some better p/3hr & local sx & no fever & crying less;
Vomiting; Massive headache; Incredibly tired; Sore right arm; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 31Mar2021 at 14:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was not allergic to food, medications, or other products. The patient did not receive any medications within two weeks prior to the COVID-19 vaccine.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, after about 3 hours from the first dose of vaccine, the patient was incredibly tired and slept. The event of incredibly tired was not that bad. The patient woke up for a little while and then went back to sleep again. On 01Apr2021 at around 06:15, the patient woke up with a massive headache. He took a couple of ibuprofen and tried to relax. About fifteen minutes later, at 06:30, the patient could tell he was about to vomit and did. He kept vomiting for about the next 20 minutes or so till there was nothing left. He slowly sipped water for the next hour. After that he had no adverse reactions. The patient stated that, he had not vomited in at least the past 7 years and that episode of vomiting was violent and also stated he could not control that. On the same day, in the evening, the patient only had a slight sore right arm and episode of tiredness. On 02Apr2021, after vomiting the patient slept for the next five or so hours. His arm was still slightly sore but really did not bother him. After around 2 PM (about 24 hours later), he had felt totally fine. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events of tiredness, vomiting and sore right arm. The clinical outcome of the event tiredness, headache, vomiting and sore right arm were resolved in 02Apr2021. No follow-up attempts are needed. No further information is expected.
Injection site and muscle pain. Gradually, left arm movement became limited, and muscle strength weak and stiff.   it lasts from Oct 3, 2020 till now.  It is more than two months, my left arm movement is still limited. .
5/18/14-STIFF NECK, MALAISE; 5/20/14-RASH BEGAN ON CHEST; 5/27/14-RASH PERSISTS AND TEMP: 99.6, FEW WHITE SPOTS IN MOUTH.
48 hours of day/time of vaccine, I started experiencing chest tightness and pain around my sternum area (approx 11 am). Unsure what this foreign sensation and pain was, I tried to rule out GERD by taking omeprazole and tums with no relief. Throughout the day I started experiencing dizzy spells and a dry cough. I went to an urgent care and they ruled out pneumonia and other cardiac abnormalities. Chest X-ray was positive for bronchitis.
Swelling, hives, and itchiness. I was given medication to reduce the reaction.
Tongue and upper lip tingling started approximately 19 minutes after the injection and lasted the entire day. I did not experience and difficulty swallowing or breathing and I did not take any other medication until bedtime, at 1130 pm. I took Ibuprofen 800mg.
Fever 102.4 7-29-09.7-28-09- Seen in ER 103.0. Fever 101.9 -7-30-09
9 x 6.6cm area of erythema, warm and mild induration just distal to injection site in left arm. Antibiotics were prescribed for cellulitis.
Sore at injection site.  Soreness became increasingly worse over the next week.  It has moved into the entire shoulder and is limiting motion and use of arm.  Very painful, no medications seem to help.  A day of activity made the pain unbearable.
Information has been received from a consumer who is a nurse concerning her 4 year old daughter who received "the normal immunization given prior to school entry including MMR II and others" (unspecified what the other vaccines were). On an unspecified date the patient developed black and blue arms in addition to firmness at the injection site areas. Several weeks later the patient recovered from black and blue arms and firmness at the injection site areas. Additional information has been requested.
The patient was nervous so I administered all 3 vaccines in the left deltoid. Patient was fine right after vaccines. He was talking  and saying how the injections didn't hurt as bad as he thought. I begin to help mom fill out paperwork. Patient was talking and stopped about 3 minutes after vaccine . I turned to patient and he seized up and fell to the ground. Patient hit the ground hard and was shaking. Mom grabbed patient and was holding his head. I gave mom paper towels to apply pressure to head laceration while calling cold blue. Patient became coherent less than a minute from falling and knew who he was but didn't know where he was or how he got on the floor. Medics came and took patient to ER for further evaluation .
Starting 11/19/2022, I developed a strong headache and congestion. By 11/21/2022, I developed a fever of around 101, body aches, diarrhea, nausea and congestion. I tested myself that day for COVID-19 and it was positive. I contacted my doctor before I tested myself for COVID-19. I was prescribed PAXLOVID right away and started it that evening. It helped me feel better right away. For 3-4 days, I had mild symptoms and then felt better. I had lingering fatigue that lasted for about a week or so after the other symptoms resolved. I am still having lingering IBS symptoms that have yet to improve. Also, I have been having weird blistering of the tongue making it hard to eat certain things, and more frequent but mild asthma symptoms.
pt recv vax 3APR97 & lab eval 2FEB97 for varicella antibodies was negative;pt was found to be pregnant by a serum pregnancy test 8MAY97;LMP 24MAR97;estimated date of delivery 30DEC97;pt exp h/a @ 16wk pregnancy tx w/med;delivered nl infant;
This spontaneous report was received from a nurse, referring to a 52 year old male patient with no pertinent medical history and no drug reactions or allergies. The patient's concomitant therapies were not provided. On an unknown date, when the patient "was a child" was vaccinated with a dose of M-M-R II injection (dose, route, lot # and expiration date were not provided) for prophylaxis. On 02-MAY-2017, the patient had unspecified laboratory test for his job and it showed that he was immune to mumps and rubella but was "equivocal for rubeola" (Rubella antibody negative). The patient did not seek medical attention. The causal relationship between M-M-R II and rubella antibody negative was not provided.
It was reported that a female pt received a Menomune A/C/Y/W-135 vaccination on 3/31/00. Reportedly, sometime after the vaccination, the pt developed stridor. Additional information is being requested. It was reported that the pt recovered from this experience.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hurting arm), PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (Lump on her left arm) and VACCINATION SITE DISCOLOURATION (Injection site is blue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No medical history was provided by reporter. No concomitant medication reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced PAIN IN EXTREMITY (Hurting arm) and PAIN IN EXTREMITY (sore arm). On 19-Apr-2021, the patient experienced VACCINATION SITE MASS (Lump on her left arm) and VACCINATION SITE DISCOLOURATION (Injection site is blue). At the time of the report, PAIN IN EXTREMITY (Hurting arm), PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (Lump on her left arm) and VACCINATION SITE DISCOLOURATION (Injection site is blue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported  The patient took TYLENOL to alleviate the symptoms on 18-APR-2021
During the injection, felt the liquid going up her neck. Told it was normal, but it was verified that it was not. Extreme pain through entire body. Could walk. Developed shingles in face 2 and a half weeks later.  After shingles, had a 2nd episode where it felt like she was having a heart attack. Had the symptoms of a heart attack. Shingles are gone, but lingering sporactic pain and itching.
Headache, sweating, shaking, paleness, fatigue. ER choose not to provide anything since they didn't know what caused the reaction.
Pt had erythema & edema noted to (L) deltoid region. Area is 8 cm in diameter.
Powder was reconstituted with sterile water and administered to patient; Powder was reconstituted with sterile water and administered to patient; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a adolescent male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA642A, expiry date 30th November 2022) for prophylaxis.   On 3rd May 2022, the patient received Menveo. On 3rd May 2022, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 04-MAY-2022 Reporters comment: The patient was 16 years old at he time of reporting. Director reported that, Menveo powder was inadvertently reconstituted with sterile water and administered to the patient. The reporter consented to follow up. Additional supportive information: Menveo powder was inadvertently reconstituted with sterile water and administered to the patient, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
This spontaneous report was received from a medical assistant refers to a male patient of unknown age. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported. On 23-APR-2018, the patient was vaccinated with expired dose of RECOMBIVAX HB (dose, units and frequency not reported) (lot # M000442 and expiration date: 31-MAR-2018) intramuscularly (expired product administered). No adverse effects were reported. Reporter confirmed that, there was no temperature excursion prior to being administered. No product quality complaint was involved.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 70-year-old male patient received BNT162b2 (BNT162B2 NOS), on 02Jan2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: COVID 19 Treatment; positive, notes: began testing positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 13Feb2023 to 17Feb2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report was received from a registered nurse regarding an unspecified patients of unknown age. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored ROTATEQ, lot # K014826, expiration date- 28-MAY-2016 and lot # K011948, expiration date- 07-JUN-2016 (incorrect product storage). No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. Temperature was -3 degree Celsius, Time frame was 6 hours and it was back in range. There was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.
UNSPECIFIED BOWEL ISSUES; ALLERGIES GETTING WORSE; This spontaneous case was reported by a health care professional and describes the occurrence of GASTROINTESTINAL DISORDER (UNSPECIFIED BOWEL ISSUES) and HYPERSENSITIVITY (ALLERGIES GETTING WORSE) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product SELEXIPAG tablet for Primary pulmonary hypertension.    Concurrent medical conditions included Primary pulmonary hypertension. Concomitant products included SILDENAFIL CITRATE for an unknown indication.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started SELEXIPAG (Oral) 200 microgram twice a day. On an unknown date, the patient experienced GASTROINTESTINAL DISORDER (UNSPECIFIED BOWEL ISSUES) and HYPERSENSITIVITY (ALLERGIES GETTING WORSE). At the time of the report, GASTROINTESTINAL DISORDER (UNSPECIFIED BOWEL ISSUES) and HYPERSENSITIVITY (ALLERGIES GETTING WORSE) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Lesion right forefinger 2 nd joint 10 x 6 mm aand right knuckle, base of ring finger, (prob. scratch).
immed following vax pt became flushed, puffy-faced, nasal congested w/c/o heart pain;dx antio-neurotic edema
mild soreness; a little swelling at the shot location; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 23Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "diverticulitis" (ongoing); "stress" (ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose-1 single), for Covid-19 immunisation, reaction(s): "not had any problems after that initial shot". The following information was reported: PAIN (non-serious), outcome "unknown", described as "mild soreness"; VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "a little swelling at the shot location".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Allergic type reaction, swelling (baseball size), redness, hot skin, no anaphylaxis signs.
Here for reaction to anthrax vaccine had AVA #3 on Mon.  Had injection tenderness, chills, bodyaches, and HA.  72 hours later developed hives on arms and neck.  Took BENADRYL and hives disappeared, but that evening they returned.  Resolved again with BENADRYL.  Had hives this am again on neck and took BENADRYL.  Body aches are gone.  No SOB, lip swelling, nausea.  Large area of erythema and tenderness and pruritis at injection site.  Does not feel her throat closing.  Did not have reactions like this to prior 2 immunizations.  No other new exposures to account for this.  Symptoms: Urticaria, Fever, Headache, general, Muscle Pain, Edema at Injection site 30-50mm, Erythema.